Larimar Therapeutics, Inc.
LRMR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374690
In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Larimar Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 104 | 107 | +3 |
| Shares | 63.6M | 65.3M | +1.71M (+2.7%) |
| Value | $482.8M | $473.5M | −$9.30M (−1.9%) |
New holders (24)
Institutions that held Larimar Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (21)
Institutions that held Larimar Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| RTW Investments, LP | 650,000 | $4.93M |
| Ghost Tree Capital, LLC | 210,603 | $1.60M |
| Opaleye Management Inc. | 174,413 | $1.32M |
| Caption Management, LLC | 142,900 | $1.08M |
| Concentric Capital Strategies, LP | 123,325 | $936.0K |
| HAP Trading, LLC | 98,984 | $751.3K |
| Qube Research & Technologies Ltd | 89,094 | $676.2K |
| Bridgeway Capital Management, LLC | 84,500 | $641.4K |
| Schonfeld Strategic Advisors LLC | 80,900 | $614.0K |
| Semanteon Capital Management, LP | 48,272 | $366.4K |
| Nomura Holdings Inc | 21,142 | $160.5K |
| Danske Bank A/S | 19,670 | $149.3K |
| Allianz Asset Management GmbH | 18,600 | $141.2K |
| Virtu Financial LLC | 17,578 | $133.0K |
| XTX Topco Ltd | 16,906 | $128.3K |
| American International Group, Inc. | 12,825 | $97.3K |
| Group One Trading, L.P. | 8,638 | $65.6K |
| Metropolitan Life Insurance Co | 1,410 | $10.7K |
| Comerica Bank | 415 | $3.15K |
| ICA Group Wealth Management, LLC | 75 | $569 |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 5 | $37 |